Pretomanid-resistant tuberculosis-Reference-Cited by-同舟云学术

Pretomanid-resistant tuberculosis

Published:2023-05 Issue:5 Volume:86 Page:520-524
ISSN:0163-4453
Container-title:Journal of Infection
language:en
Short-container-title:Journal of Infection

Author:

Koehler Niklas^ORCID,Andres Sönke,Merker Matthias,Dreyer Viola^ORCID,John Agnieszka,Kuhns Martin^ORCID,Krieger David,Choong Eva^ORCID,Verougstraete Nick,zur Wiesch Pia Abel,Wicha Sebastian G.,König Christina,Kalsdorf Barbara,Sanchez Carballo Patricia M.,Schaub Dagmar,Werngren Jim,Schön Thomas,Peloquin Charles A.,Schönfeld Nicolas,Verstraete Alain G.,Decosterd Laurent A.,Aarnoutse Rob,Niemann Stefan,Maurer Florian P.,Lange Christoph^ORCID

Funder

Deutsches Zentrum für Infektionsforschung

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical)

Reference10 articles.

1. Proteomic analysis of sequential isolates of multidrug-resistant Mycobacterium tuberculosis during treatment failure;Lee;J Infect,2022

2. World Health Organization. Global tuberculosis report 2022. Geneva: World Health Organization; 2022.

3. World Health Organization. WHO consolidated guidelines on tuberculosis: module 4: treatment: drug-resistant tuberculosis treatment. 2022 update ed. Geneva: World Health Organization; 2022.

4. A battery of tandem mass spectrometry assays with stable isotope-dilution for the quantification of 15 anti-tuberculosis drugs and two metabolites in patients with susceptible-, multidrug-resistant- and extensively drug-resistant tuberculosis;Mercier;J Chromatogr B,2022

5. A sensitive and high-throughput quantitative liquid chromatography high-resolution mass spectrometry method for therapeutic drug monitoring of 10 beta-lactam antibiotics, linezolid and two beta-lactamase inhibitors in human plasma;Van Vooren;Biomed Chromatogr,2021

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bedaquiline, pretomanid and linezolid in multidrug-resistant and pre-extensively drug-resistant tuberculosis in refugees from Ukraine and Somalia in Germany;European Respiratory Journal;2024-04-18

2. Multidrug-resistant tuberculosis;Nature Reviews Disease Primers;2024-03-24

3. Drug-resistant tuberculosis is a global cause of concern;Ugeskrift for Læger;2024-03-04

4. Bedaquiline Resistance after Effective Treatment of Multidrug-Resistant Tuberculosis, Namibia;Emerging Infectious Diseases;2024-03

5. A first-in-class leucyl-tRNA synthetase inhibitor, ganfeborole, for rifampicin-susceptible tuberculosis: a phase 2a open-label, randomized trial;Nature Medicine;2024-02-16